Showing results (611-620 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 15, 2021
Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinomaXiaomao Yin, Zaoyu Wang, Jianfeng Wang, et al.Oncoimmunology|July 8, 2021
DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profilesSepehr Safaei, Malte Mohme, Judith Niesen, et al.Oncoimmunology|July 9, 2021
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patientsGlenn F Van Wigcheren, Nienke De Haas, Tom A Mulder, et al.Oncoimmunology|February 21, 2020
Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatmentKyung Hwan Kim, Joon Young Hur, Jinhyun Cho, et al.Oncoimmunology|July 22, 2021
T cells drive negative feedback mechanisms in cancer associated fibroblasts, promoting expression of co-inhibitory ligands, CD73 and IL-27 in non-small cell lung cancerRichard A O'Connor, Vishwani Chauhan, Layla Mathieson, et al.Oncoimmunology|May 23, 2022
The ART of tumor immune escapeErik Wennerberg, Sumit Mukherjee, Ricardo M Sainz, et al.Oncoimmunology|May 13, 2022
OX40 and 4-1BB delineate distinct immune profiles in sarcomaM J Melake, H G Smith, D Mansfield, et al.Oncoimmunology|May 13, 2022
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinomaRobyn D Gartrell, Thomas Enzler, Pan S Kim, et al.Oncoimmunology|May 13, 2022
NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemiaKateřina Kuželová, Barbora Brodská, Jana Marková, et al.Oncoimmunology|January 18, 2021
Ferroptosis becomes immunogenic: implications for anticancer treatmentsDaolin Tang, Oliver Kepp, Guido KroemerPageof 379